Access to Orphan Drugs: A Cross Country Comparison of Legislative Approach Among Serbia, Croati a and Macedonia

Acta Medica Medianae
doi 10.5633/amm.2018.0406
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medical Faculty, University in Nis

Related search

Mechanism of Coordinated Access to Orphan Drugs

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2012English

A Cross Country Comparison of Exposure to Secondhand Smoke Among Youth

Tobacco Control
EnvironmentalPublic HealthHealthOccupational Health
2006English

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries

PLoS ONE
Multidisciplinary
2015English

Market Access Risk Scoring: A Unified Framework for Cross Country Comparison of Diverse Market Access Systems and Processes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Psy135 - Access to Orphan Drugs – Regulation Within the European Law

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Comparison and the Effectiveness of Tourism Policies Between Macedonia and Serbia

Turizam
2018English

Php325 - Orphan Drugs‘ Market Access Challenges in Europe From a German Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy131 - Access to Orphan Drugs (Od) in Spain: Analysis of Nusinersen’s Case

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Cross-Country Comparison of Labor Force Participation

2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy